Matinas BioPharma Investor Relations Material
Latest events
Q2 2024
Matinas BioPharma
Q2 2025
14 Aug, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Matinas BioPharma Holdings Inc
Access all reports
Matinas BioPharma Holdings Inc. is a biopharmaceutical company focused on developing lipid nanocrystal (LNC) delivery technology for the oral delivery of small molecules, gene therapies, and vaccines. The company's proprietary LNC platform aims to enhance the absorption and bioavailability of drugs, particularly those used to treat infectious diseases and cardiovascular conditions. The company is headquartered in Bedminster, New Jersey, and its shares are listed on the NYSE.
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
MTNB
Country
🇺🇸 United States